NCTId;BriefTitle;HasResults;StartDate;CompletionDate;publication_types;title;published_date;type;doi;pmid
NCT02099474;Evaluation of Raltegravir During the Third Trimester of Pregnancy;False;2014;2017;['Journal Article', 'Multicenter Study'];Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.;2020;DERIVED;10.1128/AAC.00759-20;32661003
NCT02497274;Obesity and Lipids: a Matter of Taste?;False;2016;2019;;;;;;
NCT02592174;Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study;False;2016;2017;['Journal Article'];Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.;2019;DERIVED;10.1093/cid/ciz670;31755936
NCT01490489;EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction;False;2011;2015;['Journal Article'];Role of EG-VEGF in human placentation: Physiological and pathological implications.;2008;SUSPICIOUS;10.1111/j.1582-4934.2008.00554.x;19602057
NCT01490489;EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction;False;2011;2015;['Journal Article'];Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.;2007;SUSPICIOUS;10.1016/j.placenta.2007.03.008;17531315
NCT01490489;EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction;False;2011;2015;['Journal Article'];Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.;2006;SUSPICIOUS;10.1210/en.2005-0912;16384869
NCT01552044;Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis;False;2012;2013;;;;;;
NCT02116374;Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients;False;2014;2016;;;;;;
NCT02100774;Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability;False;2009;2013;['Journal Article', 'Review'];Genetic variations involved in interindividual variability in carotenoid status.;2012;BACKGROUND;10.1002/mnfr.201100322;21957063
NCT02100774;Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability;False;2009;2013;['Journal Article'];A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Dietary β-Carotene Bioavailability in Healthy Men.;2015;DERIVED;10.3945/jn.115.212837;26063065
NCT02100774;Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability;False;2009;2013;['Journal Article', 'Randomized Controlled Trial'];Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration.;2014;DERIVED;10.3945/ajcn.114.085720;24808487
NCT02100774;Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability;False;2009;2013;['Journal Article'];A Combination of Single-Nucleotide Polymorphisms Is Associated with Interindividual Variability in Cholecalciferol Bioavailability in Healthy Men.;2016;DERIVED;10.3945/jn.116.237115;27798339
NCT02626286;Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa;False;2015;2021;['Journal Article'];Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France).;2021;DERIVED;10.1136/sextrans-2020-054755;33753460
NCT02626286;Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa;False;2015;2021;['Journal Article'];Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).;2021;DERIVED;10.1186/s12889-021-10994-4;34022820
NCT02626286;Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa;False;2015;2021;['Journal Article'];Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa.;2021;DERIVED;10.1097/QAD.0000000000003046;34352834
NCT00670839;Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST);False;2008;2013;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.;2015;DERIVED;10.1016/S1473-3099(15)00220-0;26257021
NCT03078439;EPIPAGE2 Cohort Study Follow up at Five and a Half Years;False;2016;2018;['Journal Article'];Birth weight and head circumference discordance and outcome in preterms: results from the EPIPAGE-2 cohort.;2024;PUBMED;10.1136/archdischild-2023-326336;38408861
NCT01453192;Renal Transplantation and Raltegravir in HIV-Infected Patients;False;2011;2015;['Journal Article', 'Multicenter Study'];Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.;2019;PUBMED;10.1111/hiv.12700;30688008
NCT02777229;Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings;False;2016;2021;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.;2019;DERIVED;10.1056/NEJMoa1904340;31339676
NCT02777229;Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings;False;2016;2021;['Randomized Controlled Trial', 'Journal Article'];Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).;2023;PUBMED;10.1097/QAI.0000000000003273;37851566
NCT02777229;Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings;False;2016;2021;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon.;2020;DERIVED;10.1016/S2352-3018(20)30238-1;33010241
NCT02777229;Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings;False;2016;2021;['Journal Article'];Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.;2023;PUBMED;10.1093/ofid/ofad582;38156046
NCT02777229;Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings;False;2016;2021;['Journal Article'];Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).;2020;DERIVED;10.1007/s40273-020-00987-3;33355914
NCT01895920;Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?;False;2013;2018;;;;;;
NCT04808986;Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts;False;2021;2021;;;;;;
NCT03071458;Mutational Landscape in Hepatocellular Carcinoma;False;2008;2015;;;;;;
NCT02273765;Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis;False;2015;2018;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.;2021;DERIVED;10.1016/S1473-3099(20)30869-0;33667406
NCT00658346;Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon;False;2010;2016;['Journal Article'];Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients.;2019;DERIVED;10.1093/cid/ciz371;31063537
NCT02073604;Role of the SMA During Unimanual and Bimanual Movements Preparation: the Mirror Movements Paradigm;False;2014;2016;;;;;;
NCT03047967;Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns;False;2017;2019;;;;;;
NCT02107365;Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO);False;2013;2015;;;;;;
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.;2010;BACKGROUND;10.1128/CVI.00322-09;20107007
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.;2009;BACKGROUND;10.1128/CVI.00082-09;19625486
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.;2014;BACKGROUND;10.1016/j.vaccine.2014.06.019;24950361
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.;2010;BACKGROUND;10.1016/j.vaccine.2010.08.017;20708998
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response.;2011;BACKGROUND;10.4049/jimmunol.1003765;21430219
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article', 'Randomized Controlled Trial'];Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.;2020;DERIVED;10.1016/S1473-3099(20)30274-7;32687804
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.;2011;BACKGROUND;10.1128/CVI.00371-10;21147936
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article', 'Randomized Controlled Trial'];"A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.";2014;BACKGROUND;10.1371/journal.pone.0083449;24421886
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.;2012;BACKGROUND;10.1016/j.vaccine.2012.07.005;22814407
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article', 'Randomized Controlled Trial'];B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.;2014;BACKGROUND;10.1016/j.vaccine.2014.04.048;24793938
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.;2008;BACKGROUND;10.1016/j.vaccine.2008.08.018;18762220
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article', 'Randomized Controlled Trial'];Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.;2020;DERIVED;10.1172/JCI135020;31945015
NCT02453048;Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine;True;2015;2017;['Journal Article'];T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.;2010;BACKGROUND;10.1371/journal.pone.0010178;20419113
NCT03446430;Validation of Laser Doppler Vibrometer (LDV) for Measurement of Arterial Stiffness in Hypertensive Patients;False;2018;2018;;;;;;
NCT01693848;"""Cancersensor"" Metastasis Resection";False;2012;2014;;;;;;
NCT02566148;Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France;False;2012;2013;['Journal Article'];How to use sequence analysis for life course epidemiology? An example on HIV-positive Sub-Saharan migrants in France.;2018;DERIVED;10.1136/jech-2017-209739;29437866
NCT02566148;Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France;False;2012;2013;['Journal Article'];Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study.;2018;DERIVED;10.1016/S2468-2667(17)30211-6;29307383
NCT02566148;Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France;False;2012;2013;['Journal Article'];Refusal to provide healthcare to sub-Saharan migrants in France: a comparison according to their HIV and HBV status.;2018;DERIVED;10.1093/eurpub/cky118;29982518
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.;2006;RESULT;10.1038/ng1758;16501573
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Letter'];Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases.;2005;RESULT;10.1136/jmg.2005.035311;16055926
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.;2014;DERIVED;10.1136/jmedgenet-2013-102200;24780882
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians.;2004;SUSPICIOUS;10.1212/01.wnl.0000137020.30604.1e;15365159
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article', 'Multicenter Study'];Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia.;2012;DERIVED;10.1001/archneurol.2011.2713;22491195
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10.;2009;RESULT;10.1002/humu.20920;18853458
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Letter'];A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP.;2007;RESULT;10.1007/s10048-007-0090-4;17597328
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];"A novel locus for autosomal dominant ""uncomplicated"" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3.";2007;RESULT;10.1007/s00439-007-0396-1;17605047
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article', 'Multicenter Study'];Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.;2008;RESULT;10.1093/brain/awn059;18378516
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14.;2004;SUSPICIOUS;10.1001/archneur.61.8.1242;15313841
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];Mental deficiency in three families with SPG4 spastic paraplegia.;2007;RESULT;10.1038/sj.ejhg.5201922;17957230
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Letter'];Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia.;2007;RESULT;10.1136/jmg.2006.046425;17098887
NCT00136630;Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations;False;2005;2020;['Journal Article'];New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.;2005;RESULT;10.1002/ana.20628;16193476
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.;2016;RESULT;10.1016/j.drugpo.2016.02.021;27006257
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014.;2017;RESULT;10.1007/s10461-017-1814-6;28612212
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?;2015;BACKGROUND;10.1080/10550887.2015.1059111;26075647
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.;2017;RESULT;10.1016/j.drugalcdep.2017.07.004;28800503
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.;2016;RESULT;10.1080/09540121.2016.1178698;27178119
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];AIDS, people who use drugs, and altruism: reflection on a personal image.;2014;BACKGROUND;10.3109/10826084.2015.978185;25540950
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.;2015;BACKGROUND;10.1016/j.drugpo.2015.04.015;26050614
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.;2015;BACKGROUND;10.1007/s10461-015-1113-z;26080690
NCT02573948;Feasibility of Interventions on People Who Inject Drugs in Vietnam;True;2014;2016;['Journal Article'];Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.;2015;BACKGROUND;10.1111/add.12999;26032121
NCT05040048;Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease;False;2015;2018;;;;;;
NCT05199831;Situational Analysis of HIV-related Disability in the Context of Ivory Coast;False;2021;2022;;;;;;
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.;2020;SUSPICIOUS;10.2807/1560-7917.ES.2020.25.5.2000062;32046819
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.;2020;SUSPICIOUS;10.2807/1560-7917.ES.2020.25.6.2000094;32070465
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston.;2020;SUSPICIOUS;10.1001/jama.2020.6887;32338732
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];SARS-CoV-2 was already spreading in France in late December 2019.;2020;SUSPICIOUS;10.1016/j.ijantimicag.2020.106006;32371096
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];A Novel Coronavirus from Patients with Pneumonia in China, 2019.;2020;SUSPICIOUS;10.1056/NEJMoa2001017;31978945
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];Clinical Characteristics of Coronavirus Disease 2019 in China.;2020;SUSPICIOUS;10.1056/NEJMoa2002032;32109013
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.;2020;SUSPICIOUS;10.1056/NEJMoa2001316;31995857
NCT04470648;COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey;False;2020;2021;['Journal Article'];Clinical and virological data of the first cases of COVID-19 in Europe: a case series.;2020;SUSPICIOUS;10.1016/S1473-3099(20)30200-0;32224310
NCT02081066;Identification of CETP as a Marker of Atherosclerosis;False;2014;2020;;;;;;
NCT03459157;Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP);False;2017;2021;['Journal Article'];HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.;2021;DERIVED;10.1016/S2352-3018(21)00005-9;34048794
NCT01620957;Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma;False;2012;2017;;;;;;
NCT02073630;Contribution of the Cerebellum In Sensory-motor Adaptation Via Gamma Oscillations: the Case of Dystonia;False;2014;2016;;;;;;
NCT02987530;National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection;False;2017;2020;;;;;;
NCT02160119;Emotional and Change-related Attention in Autism;False;2014;2018;;;;;;
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article', 'Review'];Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments.;2007;BACKGROUND;10.1016/j.ajog.2007.03.003;17825642
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial.;2019;DERIVED;10.1016/S2352-3018(18)30361-8;30814028
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article'];Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding.;2017;DERIVED;10.1128/AAC.01869-16;27895016
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article'];Lopinavir-Ritonavir Impairs Adrenal Function in Infants.;2019;DERIVED;10.1093/cid/ciz888;31633158
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article'];Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial.;2016;DERIVED;10.1186/s13006-017-0112-2;28469697
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.;2016;DERIVED;10.1016/S0140-6736(15)00984-8;26603917
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article'];Association of maternal HIV-1 severity with dental caries: an observational study of uninfected 5- to 7-yr-old children of HIV-1-infected mothers without severe immune suppression.;2020;DERIVED;10.1111/eos.12669;31994250
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial'];Antiretroviral treatment and its impact on oral health outcomes in 5 to 7 year old Ugandan children: A 6 year follow-up visit from the ANRS 12174 randomized trial.;2020;DERIVED;10.1097/MD.0000000000022352;32991450
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article'];The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1.;2021;PUBMED;10.1186/s12955-021-01844-3;34425825
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174.;2012;DERIVED;10.1186/1471-2334-12-246;23039034
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article'];Caries experience and oral health related quality of life in a cohort of Ugandan HIV-1 exposed uninfected children compared with a matched cohort of HIV unexposed uninfected children.;2020;DERIVED;10.1186/s12889-020-08564-1;32228542
NCT00640263;Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding;False;2009;2014;['Journal Article'];Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda.;2020;DERIVED;10.1093/cid/ciaa161;32067040
NCT03642704;HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure;False;2017;2019;;;;;;
NCT02488395;Superior Colliculus Activity in Parkinson Disease: a Potential Marker?;False;2015;2018;['Journal Article', 'Review'];Visual-motor function of the primate superior colliculus.;1980;SUSPICIOUS;10.1146/annurev.ne.03.030180.001201;6774653
NCT02488395;Superior Colliculus Activity in Parkinson Disease: a Potential Marker?;False;2015;2018;['Journal Article'];Linking visual response properties in the superior colliculus to saccade behavior.;2012;SUSPICIOUS;10.1111/j.1460-9568.2012.08079.x;22639796
NCT02488395;Superior Colliculus Activity in Parkinson Disease: a Potential Marker?;False;2015;2018;['Journal Article'];Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.;2013;SUSPICIOUS;10.1016/j.neuroscience.2013.07.047;23916713
NCT01473472;On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men;False;2012;2016;['Clinical Trial', 'Letter'];Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial.;2022;PUBMED;10.1136/sextrans-2022-055634;36601747
NCT01473472;On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men;False;2012;2016;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.;2020;DERIVED;10.1016/S2352-3018(19)30341-8;31784343
NCT01473472;On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men;False;2012;2016;['Journal Article', 'Randomized Controlled Trial'];Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.;2018;DERIVED;10.1016/S1473-3099(17)30725-9;29229440
NCT01473472;On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men;False;2012;2016;['Journal Article', 'Multicenter Study'];Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.;2017;DERIVED;10.1016/S2352-3018(17)30089-9;28747274
NCT01473472;On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men;False;2012;2016;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.;2015;DERIVED;10.1056/NEJMoa1506273;26624850
NCT01525472;Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects;False;2012;2015;;;;;;
NCT02267304;Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic);False;2013;2016;;;;;;
NCT02384967;Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients;False;2015;2016;['Journal Article', 'Multicenter Study'];Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.;2018;DERIVED;10.1093/jac/dky193;29905808
NCT00323804;Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.;False;2006;2013;;;;;;
NCT01127204;Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age;False;2011;2015;['Journal Article'];Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.;2017;DERIVED;10.7448/IAS.20.01.21362;28453240
NCT01127204;Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age;False;2011;2015;['Letter'];High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy.;2021;DERIVED;10.1097/QAD.0000000000003043;34723858
NCT01127204;Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age;False;2011;2015;['Journal Article'];Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.;2016;DERIVED;10.7448/IAS.19.1.20601;27015798
NCT01127204;Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age;False;2011;2015;['Journal Article'];Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.;2019;DERIVED;10.1093/ofid/ofz276;31334298
NCT01127204;Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age;False;2011;2015;['Journal Article'];Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old.;2017;DERIVED;10.1128/AAC.00297-17;28483965
NCT01127204;Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age;False;2011;2015;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.;2017;DERIVED;10.1111/bcp.13397;28800382
NCT01127204;Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age;False;2011;2015;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.;2017;DERIVED;10.1186/s12916-017-0842-4;28434406
NCT03109067;Genetic and Metabolism of Post-prandial HDL Particles;False;2011;2015;;;;;;
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article'];Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.;2016;BACKGROUND;10.1177/00333549161310S214;27168667
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article'];Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.;2012;BACKGROUND;10.1097/MLR.0b013e3182408812;22310560
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article'];Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.;2016;BACKGROUND;10.1080/09540121.2016.1178698;27178119
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article'];Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.;2016;BACKGROUND;10.1016/j.cmi.2016.01.009;26806260
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article'];Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.;2016;BACKGROUND;10.1017/S0950268816002934;28004616
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article'];Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C.;2022;DERIVED;10.1093/ofid/ofac181;35774932
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article'];Using dual capture/recapture studies to estimate the population size of persons who inject drugs (PWID) in the city of Hai Phong, Vietnam.;2018;BACKGROUND;10.1016/j.drugalcdep.2017.11.033;29432973
NCT04008927;A Community-based Intervention Among Active Drug Users in Montpellier;False;2020;2021;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.;2016;BACKGROUND;10.7326/M16-0816;27537841
NCT02486731;Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes;False;2015;2018;;;;;;
NCT02014727;Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults;False;2014;2015;['Journal Article', 'Randomized Controlled Trial'];Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.;2017;DERIVED;10.1016/j.vaccine.2017.09.027;28947345
NCT03671291;Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV;False;2019;2021;;;;;;
NCT01882062;Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease;True;2013;2013;['Clinical Trial', 'Journal Article'];Triheptanoin improves brain energy metabolism in patients with Huntington disease.;2015;RESULT;10.1212/WNL.0000000000001214;25568297
NCT02542891;European Comparative Effectiveness Research on Internet-based Depression Treatment;False;2015;2018;['Journal Article', 'Randomized Controlled Trial'];Comparison of the Working Alliance in Blended Cognitive Behavioral Therapy and Treatment as Usual for Depression in Europe: Secondary Data Analysis of the E-COMPARED Randomized Controlled Trial.;2024;PUBMED;10.2196/47515;38819882
NCT02542891;European Comparative Effectiveness Research on Internet-based Depression Treatment;False;2015;2018;['Journal Article'];Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study.;2021;DERIVED;10.2196/32007;34874888
NCT02542891;European Comparative Effectiveness Research on Internet-based Depression Treatment;False;2015;2018;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries.;2016;DERIVED;10.1186/s13063-016-1511-1;27488181
NCT02650427;A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection;False;2016;2018;;;;;;
NCT03546127;Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study;False;2017;2017;;;;;;
NCT01022476;Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients;False;2010;2013;;;;;;
NCT01771562;Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent;False;2013;2016;['Journal Article'];Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study.;2018;DERIVED;10.1186/s12879-018-3282-7;30081838
NCT01771562;Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent;False;2013;2016;['Journal Article'];Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study.;2016;DERIVED;10.1177/0379572116679053;27881690
NCT01033760;Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM);False;2010;2013;['Journal Article', 'Randomized Controlled Trial'];Impact of early cART on HIV blood and semen compartments at the time of primary infection.;2017;DERIVED;10.1371/journal.pone.0180191;28708873
NCT01033760;Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM);False;2010;2013;['Journal Article', 'Randomized Controlled Trial'];Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.;2015;DERIVED;10.1016/S1473-3099(15)70021-6;25701561
NCT04780191;Investigation of Treatment Using the MyoRegulator® Device in Patients With Spasticity in the Lower Limb Due to Stroke;False;2018;2021;['Journal Article'];Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation.;2019;BACKGROUND;10.1186/s42234-019-0028-9;32232101
NCT05349162;Epicardial vs. Transvenous ICDs in Children;False;2003;2022;['Clinical Trial', 'Journal Article'];Epicardial vs. transvenous implantable cardioverter defibrillators in children.;2023;PUBMED;10.1093/europace/euad015;36735263
NCT01066962;Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects;False;2010;2013;['Journal Article'];Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.;2021;DERIVED;10.1016/S2352-3018(21)00006-0;33794182
NCT01066962;Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects;False;2010;2013;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.;2014;DERIVED;10.1016/S0140-6736(14)61170-3;25103176
NCT01066962;Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects;False;2010;2013;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.;2018;DERIVED;10.1097/QAI.0000000000001834;30365452
NCT01066962;Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects;False;2010;2013;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.;2015;DERIVED;10.1016/S2352-3018(15)00181-2;26520926
NCT01703962;Non Invasive IDentification of Gliomas With IDH1 Mutation;False;2012;2014;['Journal Article'];Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy.;2023;PUBMED;10.1148/radiol.223255;37668523
NCT01335529;Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin;False;2011;2014;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.;2016;DERIVED;10.1080/15284336.2015.1135553;27077673
NCT03298360;A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a;False;2018;2020;;;;;;
NCT01508494;Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment;False;2011;2016;;;;;;
NCT02078076;IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère;False;2013;2015;;;;;;
NCT01725542;Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders;False;2012;2014;['Journal Article', 'Multicenter Study'];High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.;2015;DERIVED;10.1093/cid/civ381;25977266
NCT04265742;Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture;False;2019;2022;;;;;;
NCT02212379;Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL;True;2015;2018;['Journal Article', 'Multicenter Study'];Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.;2019;PUBMED;10.1093/jac/dkz224;31269208
NCT01332955;Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen;False;2011;2013;['Journal Article'];Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.;2014;DERIVED;10.1093/cid/ciu659;25139963
NCT03335995;Stroke Prognosis in Intensive CarE;False;2017;2020;['Multicenter Study', 'Journal Article'];One-Year Outcomes in Patients With Acute Stroke Requiring Mechanical Ventilation.;2023;PUBMED;10.1161/STROKEAHA.123.042910;37497675
NCT03335995;Stroke Prognosis in Intensive CarE;False;2017;2020;['Journal Article'];Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study.;2020;DERIVED;10.1007/s12028-019-00907-0;32026446
NCT01432821;Blinking and Yawning in Epilepsy: The Role of Dopamine;False;2011;2014;['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial'];Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects.;2003;SUSPICIOUS;10.1046/j.1472-8206.2003.00152.x;12914551
NCT01432821;Blinking and Yawning in Epilepsy: The Role of Dopamine;False;2011;2014;['Journal Article'];Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.;2005;SUSPICIOUS;10.1016/j.eplepsyres.2005.02.002;15777732
NCT01432821;Blinking and Yawning in Epilepsy: The Role of Dopamine;False;2011;2014;['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial'];Apomorphine-induced blinking and yawning in healthy volunteers.;1990;SUSPICIOUS;10.1111/j.1365-2125.1990.tb03848.x;2271377
NCT01432821;Blinking and Yawning in Epilepsy: The Role of Dopamine;False;2011;2014;['Journal Article'];PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy.;2004;SUSPICIOUS;10.1212/01.wnl.0000132840.40838.13;15249613
NCT01432821;Blinking and Yawning in Epilepsy: The Role of Dopamine;False;2011;2014;['Journal Article'];Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat.;2004;SUSPICIOUS;10.1038/sj.bjp.0705737;15037514
NCT02738502;Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors;False;2016;2020;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.;2013;BACKGROUND;10.1093/cid/cit390;23766338
NCT02738502;Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors;False;2016;2020;['Journal Article'];Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination.;2013;BACKGROUND;10.1093/infdis/jit149;23559464
NCT02738502;Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors;False;2016;2020;['Journal Article', 'Multicenter Study'];No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.;2015;BACKGROUND;10.1093/cid/civ578;26197844
NCT02738502;Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors;False;2016;2020;['Journal Article', 'Meta-Analysis'];Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.;2015;BACKGROUND;10.1111/hiv.12348;26709605
NCT02738502;Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors;False;2016;2020;['Journal Article', 'Multicenter Study'];Risk of cancer in children exposed to didanosine in utero.;2016;BACKGROUND;10.1097/QAD.0000000000001051;26854809
NCT02738502;Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors;False;2016;2020;['Journal Article', 'Randomized Controlled Trial'];Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.;2011;BACKGROUND;10.1093/jac/dkr504;22160145
NCT02738502;Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors;False;2016;2020;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.;2012;BACKGROUND;10.1371/journal.pone.0041390;22848481
NCT01226446;Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders;False;2010;2013;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.;2015;DERIVED;10.3748/wjg.v21.i18.5647;25987791
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];The clinical picture of frontotemporal dementia: diagnosis and follow-up.;1999;BACKGROUND;10.1159/000051206;10436334
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article', 'Review'];Apathy: a neuropsychiatric syndrome.;1991;BACKGROUND;10.1176/jnp.3.3.243;1821241
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Clinical Trial', 'Journal Article'];Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.;2009;BACKGROUND;10.1212/WNL.0b013e3181c34b34;19933975
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration.;2012;BACKGROUND;10.1037/a0025318;21895376
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment.;2002;BACKGROUND;10.1002/gps.755;12461757
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?;2005;BACKGROUND;10.1136/jnnp.2003.033258;15897497
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article', 'Review'];Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.;2006;BACKGROUND;10.1016/j.brainresbull.2006.06.007;17027767
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article', 'Review'];Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.;2000;BACKGROUND;10.1016/s0166-2236(00)01626-x;10941190
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];Group differences in the relationship between apathy and depression.;1994;BACKGROUND;10.1097/00005053-199404000-00008;10678322
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy.;2006;BACKGROUND;10.1080/02699050500443467;16421064
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];The Lille Apathy Rating Scale: validation of a caregiver-based version.;2008;BACKGROUND;10.1002/mds.21968;18307266
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article'];A longitudinal view of apathy and its impact after stroke.;2009;BACKGROUND;10.1161/STROKEAHA.109.554410;19713543
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article', 'Review'];Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.;2005;BACKGROUND;10.1093/cercor/bhj043;16207933
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article', 'Review'];Apathy and the basal ganglia.;2006;BACKGROUND;10.1007/s00415-006-7012-5;17131230
NCT02496312;Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.;False;2015;2015;['Journal Article', 'Review'];Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions.;2009;BACKGROUND;10.1080/09602010902949207;19533496
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Venous Nicking Without Arteriovenous Contact: The Role of the Arteriolar Microenvironment in Arteriovenous Nickings.;2015;RESULT;10.1001/jamaophthalmol.2015.1132;25997175
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];High-resolution imaging of gunn's dots.;2015;RESULT;10.1097/IAE.0000000000000269;25077537
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Clinical Trial', 'Journal Article'];Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes.;2014;RESULT;10.1097/HJH.0000000000000095;24406779
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article', 'Review'];Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases.;2018;RESULT;10.1016/j.preteyeres.2018.07.001;30010022
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Retinal vasculitis imaging by adaptive optics.;2014;RESULT;10.1016/j.ophtha.2013.12.036;24576889
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Clinical Trial', 'Journal Article'];The Negative Cone Mosaic: A New Manifestation of the Optical Stiles-Crawford Effect in Normal Eyes.;2015;RESULT;10.1167/iovs.15-17022;26523388
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics.;2016;RESULT;10.1097/HJH.0000000000000894;27065002
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Electrophysiological features and multimodal imaging in ritonavir-related maculopathy.;2017;RESULT;10.1007/s10633-017-9612-z;28900746
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives.;2016;RESULT;10.1038/hr.2016.26;27009576
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.;2016;DERIVED;10.1097/IAE.0000000000000737;26418443
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study.;2019;RESULT;10.1080/09273948.2019.1646773;31573376
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article', 'Multicenter Study'];IN VIVO OBSERVATION OF RETINAL VASCULAR DEPOSITS USING ADAPTIVE OPTICS IMAGING IN FABRY DISEASE.;2020;RESULT;10.1097/IAE.0000000000002648;31568064
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];ATTENUATION OUTER RETINAL BANDS ON OPTICAL COHERENCE TOMOGRAPHY FOLLOWING MACULAR EDEMA: A Possible Manifestation of Photoreceptor Misalignment.;2020;RESULT;10.1097/IAE.0000000000002738;31922497
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Adaptive optics imaging of geographic atrophy.;2013;RESULT;10.1167/iovs.12-10672;23620431
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy.;2015;RESULT;10.1007/s00417-015-3136-6;26344727
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];IGF-1 is an independent predictor of retinal arterioles remodeling in subjects with uncontrolled acromegaly.;2020;RESULT;10.1530/EJE-19-0390;31972545
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Functional and high resolution retinal imaging assessment in a case of ocular siderosis.;2013;RESULT;10.1007/s10633-013-9421-y;24337723
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Letter'];Vision loss after chemotherapy: an irinotecan-induced retinopathy.;2019;RESULT;10.1016/j.ejca.2019.02.015;30947025
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];Meaning of visualizing retinal cone mosaic on adaptive optics images.;2015;RESULT;10.1016/j.ajo.2014.09.043;25284764
NCT01546181;Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases;False;2010;2017;['Journal Article'];DIRECTIONAL VARIABILITY OF FUNDUS REFLECTANCE IN ACUTE MACULAR NEURORETINOPATHY: EVIDENCE FOR A CONTRIBUTION OF THE STILES-CRAWFORD EFFECT.;2018;RESULT;10.1097/ICB.0000000000000701;29369084
NCT02323308;Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination;False;2010;2014;;;;;;
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article', 'Randomized Controlled Trial'];The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).;2018;DERIVED;10.1002/jia2.25128;30027600
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article'];Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.;2019;DERIVED;10.1002/jia2.25402;31637821
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Clinical Trial', 'Journal Article'];"""If you are here at the clinic, you do not know how many people need help in the community"": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat.";2018;DERIVED;10.1371/journal.pone.0202473;30412926
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article'];Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.;2018;DERIVED;10.1093/cid/ciy881;30321314
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article'];Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.;2017;DERIVED;10.1093/cid/cix015;28329393
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article', 'Randomized Controlled Trial'];Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.;2013;DERIVED;10.1186/1745-6215-14-230;23880306
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article', 'Randomized Controlled Trial'];Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.;2018;DERIVED;10.1016/S2352-3018(17)30205-9;29199100
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article'];Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.;2015;DERIVED;10.1186/s12889-015-1344-y;25880823
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article', 'Randomized Controlled Trial'];Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.;2016;DERIVED;10.1371/journal.pmed.1002107;27504637
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article'];Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.;2020;DERIVED;10.1371/journal.pone.0239513;32970730
NCT01509508;Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence;False;2012;2016;['Journal Article', 'Randomized Controlled Trial'];Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.;2018;DERIVED;10.1002/jia2.25112;29890048
NCT02469350;Serious Game for Parkinson's Disease Patients;False;2015;2017;['Clinical Trial', 'Journal Article'];The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study.;2018;DERIVED;10.1186/s12984-018-0375-x;29636105
NCT01942655;IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection;False;2014;2018;;;;;;
NCT02992184;PoC-HCV Genedrive Viral Detection Assay Validation Study;False;2016;2016;['Clinical Trial', 'Journal Article'];Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.;2018;DERIVED;10.1136/gutjnl-2017-315783;29615488
NCT02126384;Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response;False;2014;2016;;;;;;
NCT02071784;Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL);False;2014;2016;;;;;;
NCT01874808;From Movement Preparation to Gait Execution in ALS;False;2013;2015;;;;;;
NCT02314208;Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5;False;2015;2018;;;;;;
NCT01696708;Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease;False;2012;2015;['Clinical Trial', 'Journal Article'];Triheptanoin improves brain energy metabolism in patients with Huntington disease.;2015;DERIVED;10.1212/WNL.0000000000001214;25568297
NCT01348308;Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients;False;2011;2016;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.;2020;DERIVED;10.7326/M19-2133;32040959
NCT00946595;Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients;False;2009;2014;['Journal Article', 'Randomized Controlled Trial'];Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.;2018;DERIVED;10.1093/cid/ciy382;29767684
NCT00946595;Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients;False;2009;2014;['Journal Article'];Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).;2019;DERIVED;10.1007/s41669-019-0130-7;30968368
NCT01555450;Study of Patient Navigation to Reduce Social Inequalities;False;2011;2013;['Journal Article', 'Randomized Controlled Trial'];Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial.;2017;DERIVED;10.1016/j.ypmed.2017.08.012;28823681
NCT01555450;Study of Patient Navigation to Reduce Social Inequalities;False;2011;2013;['Journal Article', 'Review'];[Social inequalities in health from observational studies to intervention: can the patient navigator reduce social inequalities in cancer patients?].;2011;BACKGROUND;10.1016/j.respe.2010.10.008;21256688
NCT01555450;Study of Patient Navigation to Reduce Social Inequalities;False;2011;2013;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled Trial.;2018;DERIVED;10.1016/j.jval.2017.09.020;29909873
NCT03870438;Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention;False;2019;2022;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.;2016;BACKGROUND;10.1016/S0140-6736(15)00984-8;26603917
NCT03870438;Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention;False;2019;2022;['Journal Article'];Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso.;2021;BACKGROUND;10.1016/j.cct.2021.106402;33872801
NCT03870438;Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention;False;2019;2022;['Randomized Controlled Trial', 'Journal Article'];Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.;2024;PUBMED;10.1016/S0140-6736(23)02464-9;38484756
NCT01647295;Social Interactions: Ocular Explorations and Pupillometry in Autism;False;2013;2019;;;;;;
NCT01426243;The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.;False;2011;2017;['Journal Article'];Molecular characterization of the 17D-204 yellow fever vaccine.;2015;PUBMED;10.1016/j.vaccine.2015.08.055;26314624
NCT01426243;The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.;False;2011;2017;['Journal Article'];Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.;2018;DERIVED;10.1097/QAD.0000000000001963;30096071
NCT03519503;Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety;False;2017;2018;['Journal Article', 'Review'];HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1.;2012;BACKGROUND;10.1126/scitranslmed.3003327;22814853
NCT03519503;Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety;False;2017;2018;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.;2016;BACKGROUND;10.1016/S0140-6736(15)00984-8;26603917
NCT03519503;Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety;False;2017;2018;['Journal Article', 'Review'];Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.;2011;BACKGROUND;10.1097/QAI.0b013e318221c56a;21602695
NCT02113943;Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation;False;2014;2014;;;;;;
NCT01605890;Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients;True;2012;2015;['Journal Article', 'Multicenter Study'];First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).;2018;DERIVED;10.1093/cid/ciy245;29590335
NCT03652090;Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis;False;2010;2016;;;;;;
NCT01514890;French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin;False;2011;2014;['Journal Article', 'Multicenter Study'];Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.;2014;DERIVED;10.1053/j.gastro.2014.03.051;24704719
NCT01514890;French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin;False;2011;2014;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.;2015;DERIVED;10.1111/liv.12759;25556540
NCT01514890;French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin;False;2011;2014;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.;2013;DERIVED;10.1016/j.jhep.2013.04.035;23669289
NCT03150290;Brown Adipose Tissue in ALS;False;2017;2019;;;;;;
NCT00928187;Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé);True;2009;2015;['Journal Article'];Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.;2019;DERIVED;10.1007/s41669-019-0157-9;31273686
NCT00116454;Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis;False;2005;2013;;;;;;
NCT03954054;Therapeutic Education for Harm Reduction in People With Alcohol Use Disorder;False;2019;2021;['Journal Article'];Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).;2022;DERIVED;10.1186/s12954-021-00587-0;35012570
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.;2012;RESULT;10.3851/IMP2419;23052829
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.;2015;RESULT;10.1097/QAD.0000000000000787;26372388
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.;2012;RESULT;10.1016/j.jhep.2011.11.009;22173166
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response.;2014;RESULT;10.1097/QAD.0000000000000218;24499953
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Multicenter Study'];HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients.;2015;RESULT;10.1016/j.jcv.2015.10.010;26528903
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).;2017;RESULT;10.1097/MEG.0000000000000883;28418984
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Letter', 'Comment'];Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13).;2012;RESULT;10.1002/hep.25813;22535683
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).;2016;RESULT;10.1111/dar.12398;27073179
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Multicenter Study'];Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?;2012;RESULT;10.1097/QAD.0b013e32835763a4;22781224
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.;2013;RESULT;10.1111/hiv.12023;23461846
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Multicenter Study'];Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.;2010;RESULT;10.1016/j.jhep.2010.03.007;20493576
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Multicenter Study'];Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.;2021;DERIVED;10.1016/j.jhep.2020.08.008;32798585
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.;2016;RESULT;10.1093/cid/ciw379;27317796
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician.;2011;RESULT;10.1016/j.drugalcdep.2010.09.025;21239121
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.;2010;RESULT;10.1186/1471-2334-10-303;20969743
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Letter'];Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: results from ANRS CO13 HEPAVIH.;2012;RESULT;10.1016/j.jhep.2011.08.005;21888878
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.;2011;RESULT;10.1111/j.1365-2893.2010.01417.x;21692942
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Multicenter Study'];Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).;2013;RESULT;10.1111/add.12149;23421419
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.;2012;RESULT;10.1371/journal.pone.0050289;23226258
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Letter', 'Comment'];High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.;2014;RESULT;10.1093/cid/ciu525;25015913
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Review'];Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.;2014;RESULT;10.1586/17474124.2014.888949;24580042
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Multicenter Study'];Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.;2017;RESULT;10.1016/j.jhep.2017.08.005;28942916
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.;2017;RESULT;10.1111/add.13851;28430385
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.;2011;RESULT;10.1111/j.1360-0443.2011.03608.x;21819472
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.;2017;RESULT;10.1016/j.jhep.2017.02.012;28235612
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.;2014;RESULT;10.1016/j.jhep.2013.08.014;23978720
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants.;2021;DERIVED;10.1111/hiv.13127;34212476
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Comment', 'Letter'];Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers.;2010;RESULT;10.1001/archinternmed.2010.330;20876416
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article', 'Multicenter Study'];Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).;2016;RESULT;10.1097/MEG.0000000000000664;27177169
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.;2016;RESULT;10.1002/hep.28695;27339598
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).;2012;RESULT;10.1186/1472-6963-12-59;22409788
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.;2011;RESULT;10.1016/j.vaccine.2011.08.125;21920402
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?;2012;RESULT;10.1016/j.jviromet.2012.01.006;22285372
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients.;2019;DERIVED;10.1097/QAI.0000000000001940;30570526
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.;2013;RESULT;10.3851/IMP2699;24166726
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Letter', 'Comment'];Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).;2017;RESULT;10.1007/s10620-017-4703-y;28780609
NCT03324633;Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV;False;2005;2022;['Journal Article'];Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).;2015;RESULT;10.1093/cid/civ217;25778750
NCT04842851;Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle;False;2004;2020;;;;;;
NCT02408354;Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood;False;2015;2017;['Journal Article', 'Randomized Controlled Trial'];A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.;2017;DERIVED;10.1186/s13023-017-0713-2;28969699
NCT01089387;Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction;False;2010;2015;['Journal Article'];Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study.;2016;PUBMED;10.1016/j.eururo.2015.09.026;26439886
NCT01089387;Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction;False;2010;2015;['Letter'];Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial.;2017;DERIVED;10.1016/j.euf.2017.06.009;28753830
NCT01089387;Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction;False;2010;2015;['Journal Article'];Mesenchymal stem cell therapy for the treatment of erectile dysfunction.;2015;DERIVED;10.1111/jsm.12871;25974235
NCT02027233;Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults;False;2014;2022;;;;;;
NCT02428816;Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes;False;2013;2016;;;;;;
NCT04631224;Longitudinal Analysis of Oral Communication in Friedreich's Ataxia;False;2015;2017;;;;;;
NCT02886416;Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity;False;2016;2017;;;;;;
NCT02978924;Trans-spinal Direct Current Stimulation in Primary Orthostatic Tremor;False;2017;2017;;;;;;
NCT01779713;Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage;False;2013;2016;['Journal Article'];Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage.;2018;DERIVED;10.1161/STROKEAHA.118.021101;30354977
NCT02057796;Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3;False;2014;2018;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.;2020;DERIVED;10.1056/NEJMoa1910708;32558469
NCT02057796;Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3;False;2014;2018;['Journal Article'];High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF® for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.;2023;PUBMED;10.1093/cid/ciad125;36883573
NCT01493934;Development of a Fast Measurement Technique of Insulin Resistance in Human;False;2010;2013;;;;;;
NCT01693835;"""Cancersensor"": Circadian Rhythms";False;2012;2014;;;;;;
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.;2013;RESULT;10.1093/cid/cit729;24253249
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Risk of triple-class virological failure in children with HIV: a retrospective cohort study.;2011;RESULT;10.1016/S0140-6736(11)60208-0;21511330
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article', 'Multicenter Study'];Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants.;2009;RESULT;10.1097/QAD.0b013e328326ca37;19194272
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).;2010;RESULT;10.1086/653674;20536367
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.;2016;RESULT;10.1016/S2352-3018(15)00232-5;26762993
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Low birth weight in perinatally HIV-exposed uninfected infants: observations in urban settings in Cameroon.;2014;RESULT;10.1371/journal.pone.0093554;24705410
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article', 'Multicenter Study'];Response to combination antiretroviral therapy: variation by age.;2008;RESULT;10.1097/QAD.0b013e3282f88d02;18614870
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.;2011;RESULT;10.1093/cid/cir950;22198788
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article', 'Multicenter Study'];Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.;2014;RESULT;10.1097/INF.0000000000000450;24945880
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.;2007;RESULT;10.1086/521165;17712765
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.;2011;RESULT;10.1097/QAD.0b013e32834d614c;21971357
NCT03235258;Cohort of HIV-infected Children;False;2004;2020;['Journal Article'];Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.;2012;RESULT;10.1093/infdis/jis233;22427678
NCT01713335;Proteasis Evaluation in COPD;False;2012;2017;;;;;;
NCT04684758;HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study;False;2021;2022;;;;;;
NCT02192658;Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa;False;2014;2016;['Journal Article'];HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations.;2016;DERIVED;10.1136/bmjopen-2015-008934;26846895
NCT01899196;Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients;False;2013;2016;;;;;;
NCT01842919;Dance and Huntington Disease;False;2013;2016;;;;;;
NCT01801618;National Evaluation of PI-based 2nd Line Efficacy in Cambodia;False;2013;2014;['Journal Article'];Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.;2018;PUBMED;10.3389/fpubh.2018.00063;29662875
NCT02405013;Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa;False;2015;2017;['Journal Article'];Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial).;2023;PUBMED;10.1016/j.jhepr.2022.100665;36686592
NCT02051413;Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN);False;2014;2018;;;;;;
NCT05311865;Transmission of Covid-19 During Clubbing Events in Closed Places;False;2021;2022;['Journal Article'];Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.;2022;PUBMED;10.3389/fpubh.2022.981213;36438274
NCT05311865;Transmission of Covid-19 During Clubbing Events in Closed Places;False;2021;2022;['Journal Article'];A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study).;2023;PUBMED;10.1093/cid/ciad603;37795682
NCT01207986;Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study;False;2011;2014;;;;;;
NCT01579435;Experimental Therapeutics in Essential Tremor Using Transcranial Direct Current Stimulation;False;2012;2013;;;;;;
NCT02527096;A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol);False;2015;2017;;;;;;
NCT03005652;Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline;False;2017;2018;['Clinical Trial', 'Journal Article'];Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults.;2022;DERIVED;10.1212/WNL.0000000000200951;35853750
NCT03005652;Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline;False;2017;2018;['Journal Article', 'Randomized Controlled Trial'];Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial.;2022;DERIVED;10.1186/s13195-022-01057-w;36068621
NCT03005652;Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline;False;2017;2018;['Randomized Controlled Trial', 'Journal Article'];Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial.;2023;PUBMED;10.1371/journal.pone.0295175;38100477
NCT03005652;Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline;False;2017;2018;['Journal Article', 'Randomized Controlled Trial'];Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial.;2021;DERIVED;10.1159/000515669;33873195
NCT01779752;Vestibular Cortex and TMS;False;2013;2016;;;;;;
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.;2016;BACKGROUND;10.1080/09540121.2016.1178698;27178119
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Review'];Global epidemiology and genotype distribution of the hepatitis C virus infection.;2014;BACKGROUND;10.1016/j.jhep.2014.07.027;25086286
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.;2009;BACKGROUND;10.1007/s11524-009-9417-9;20041309
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.;2016;BACKGROUND;10.1016/j.jhep.2016.06.015;27349488
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Vietnamese community screening for hepatitis B virus and hepatitis C virus.;2010;BACKGROUND;10.1111/j.1365-2893.2010.01278.x;20196807
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.;2012;BACKGROUND;10.1111/j.1360-0443.2012.03932.x;22564041
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Meta-Analysis', 'Review'];Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.;2015;BACKGROUND;10.1016/j.drugpo.2015.07.004;26298331
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Review'];The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.;2016;BACKGROUND;10.1016/S0140-6736(16)30856-X;27427455
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Meta-Analysis', 'Review'];Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.;2013;BACKGROUND;10.1002/hep.26141;23172780
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];High prevalence of Hepatitis C virus genotype 6 in Vietnam.;;BACKGROUND;;19839502
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Review'];From non-A, non-B hepatitis to hepatitis C virus cure.;2015;BACKGROUND;10.1016/j.jhep.2015.02.006;25920094
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.;2013;BACKGROUND;10.1093/cid/cit377;23728143
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Review'];Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action.;2012;BACKGROUND;10.1111/j.1440-1746.2011.06974.x;22098550
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Practice Guideline'];EASL Recommendations on Treatment of Hepatitis C 2016.;2017;BACKGROUND;10.1016/j.jhep.2016.09.001;27667367
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.;2013;BACKGROUND;10.1093/cid/cit296;23884064
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.;2010;BACKGROUND;10.1002/jmv.21787;20572071
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).;2016;BACKGROUND;10.1371/journal.pone.0153744;27148964
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.;2013;BACKGROUND;10.1002/hep.26431;23553643
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.;2015;BACKGROUND;10.1016/j.drugpo.2014.08.014;25245939
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article'];Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).;2020;DERIVED;10.1136/bmjopen-2020-039234;33208326
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Review'];Current and future therapies for hepatitis C virus infection.;2013;BACKGROUND;10.1056/NEJMra1213651;23675659
NCT03537196;DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C);False;2018;2022;['Journal Article', 'Review'];Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.;2012;BACKGROUND;10.1177/1545109712453939;22828983
NCT02038842;Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers;False;2014;2016;;;;;;
NCT00265642;Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C;False;2006;2013;;;;;;
NCT01592175;Magnetoencephalography (MEG), Attention and Conscience;False;2012;2013;;;;;;
NCT03831906;Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia);False;2019;2021;['Journal Article', 'Randomized Controlled Trial'];Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial.;2021;BACKGROUND;10.1186/s12887-021-02576-5;33743621
NCT03831906;Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia);False;2019;2021;['Journal Article', 'Meta-Analysis'];Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.;2020;DERIVED;10.1002/14651858.CD013359.pub2;32853411
NCT03831906;Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia);False;2019;2021;['Randomized Controlled Trial', 'Journal Article'];Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial.;2023;DERIVED;10.1016/S1473-3099(22)00668-5;36395782
NCT00604149;Cardiac AResT And GENEtic;False;2008;2014;;;;;;
NCT00445575;Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone;False;2007;2017;;;;;;
NCT03215732;Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal;False;2017;2019;['Journal Article'];Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey).;2023;PUBMED;10.1186/s12889-023-15710-y;37143029
NCT03215732;Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal;False;2017;2019;['Journal Article'];Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356).;2019;DERIVED;10.1136/bmjopen-2019-030211;31320358
NCT02102737;Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique;False;2014;2018;;;;;;
NCT01492985;Lipopeptide Immunisation With GTU-multiHIV Trial;False;2013;2017;['Journal Article', 'Randomized Controlled Trial'];A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.;2021;DERIVED;10.1128/JVI.02165-20;33568510
NCT00918307;Efficacy and Safety of Varenicline Among HIV-infected Patients;False;2009;2014;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.;2018;DERIVED;10.1016/S2352-3018(18)30002-X;29329763
NCT00918307;Efficacy and Safety of Varenicline Among HIV-infected Patients;False;2009;2014;['Journal Article', 'Meta-Analysis', 'Review'];Interventions for preventing weight gain after smoking cessation.;2021;DERIVED;10.1002/14651858.CD006219.pub4;34611902
NCT02656407;Intraoperative Functional Ultrasound;False;2016;2018;['Journal Article'];Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity.;2015;BACKGROUND;10.1109/TMI.2015.2428634;25955583
NCT01952587;X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study;False;2013;2015;;;;;;
NCT01693861;"""Cancersensor"" Chemotherapy";False;2012;2015;;;;;;
NCT02014883;Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS;False;2013;2019;['Clinical Trial', 'Journal Article'];Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency.;2015;DERIVED;10.1136/jnnp-2015-311475;26536893
NCT02027051;Etude génétique Des Arméniens;False;2014;2017;;;;;;
NCT02093754;Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients;False;2014;2016;;;;;;
NCT01880151;Neuroelectrical Biomarkers for Alzheimer's Disease Stages;False;2013;2019;;;;;;
NCT01688453;Overweight Management and Social Inequalities;False;2012;2015;['Journal Article'];Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-INÈS trial.;2022;PUBMED;10.1017/S136898002200057X;35272723
NCT01688453;Overweight Management and Social Inequalities;False;2012;2015;['Journal Article'];Reach and Acceptability of a Mobile Reminder Strategy and Facebook Group Intervention for Weight Management in Less Advantaged Adolescents: Insights From the PRALIMAP-INÈS Trial.;2018;DERIVED;10.2196/mhealth.7657;29776897
NCT01688453;Overweight Management and Social Inequalities;False;2012;2015;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Using facilitator-receiver peer dyads matched according to socioeconomic status to promote behaviour change in overweight adolescents: a feasibility study.;2018;DERIVED;10.1136/bmjopen-2017-019731;29934380
NCT01688453;Overweight Management and Social Inequalities;False;2012;2015;['Journal Article', 'Multicenter Study'];Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity.;2020;DERIVED;10.1016/j.ypmed.2020.106043;32097754
NCT01688453;Overweight Management and Social Inequalities;False;2012;2015;['Journal Article'];Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents.;2021;DERIVED;10.1016/j.ypmed.2021.106668;34087324
NCT01688453;Overweight Management and Social Inequalities;False;2012;2015;['Journal Article'];Reducing social inequalities in access to overweight and obesity care management for adolescents: The PRALIMAP-INÈS trial protocol and inclusion data analysis.;2017;DERIVED;10.1016/j.conctc.2017.05.010;29696179
NCT02329054;Efficacy of Favipiravir Against Ebola (JIKI);False;2014;2015;['Clinical Trial', 'Journal Article'];Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.;2017;DERIVED;10.1371/journal.pntd.0005389;28231247
NCT02329054;Efficacy of Favipiravir Against Ebola (JIKI);False;2014;2015;['Published Erratum'];Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.;2016;RESULT;10.1371/journal.pmed.1002009;27046271
NCT02329054;Efficacy of Favipiravir Against Ebola (JIKI);False;2014;2015;['Letter'];Dose regimen of favipiravir for Ebola virus disease.;2015;BACKGROUND;10.1016/S1473-3099(14)71047-3;25435054
NCT02329054;Efficacy of Favipiravir Against Ebola (JIKI);False;2014;2015;['Clinical Trial', 'Journal Article'];Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.;2016;DERIVED;10.1371/journal.pmed.1001967;26930627
NCT01463956;Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation;False;2012;2015;;;;;;
NCT02647632;Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir;False;2016;2017;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.;2017;DERIVED;10.1093/cid/cix916;29077864
NCT01269632;Cohort of Young Adults Infected With HIV Since Birth or During Childhood;False;2010;2018;;;;;;
NCT02906137;Gut-Associated Lymphocyte Trafficking;False;2017;2020;;;;;;
NCT02346409;Cerebello-thalamo-cortical Coupling in Essential Tremor;False;2015;2018;;;;;;
NCT05090956;Developpement of 3T MRI Protocol;False;2012;2020;;;;;;
NCT01569399;Efficacity of rTMS in Alcohol Dependance;False;2011;2016;;;;;;
NCT01094899;Abnormal Structure and Bone Density in Diabetes;False;2010;2014;;;;;;
NCT03193099;Decoding Presymptomatic White Matter Changes in Huntington Disease;False;2017;2019;;;;;;
NCT02542800;The Influence of Collective Schemas on Individual Memory;False;2015;2017;;;;;;
NCT01917175;Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire;False;1997;2018;;;;;;
NCT02125500;Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection;False;2014;2015;;;;;;
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.;2010;BACKGROUND;10.1097/QAD.0b013e32833dec20;20802297
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study.;2012;BACKGROUND;10.3851/IMP2443;23075703
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article'];A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.;2008;BACKGROUND;10.1086/589622;18540803
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Classical Article', 'Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.;2008;BACKGROUND;10.1097/QAD.0b013e3282f4243b;18097218
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Randomized Controlled Trial'];Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).;2012;BACKGROUND;10.3851/IMP2253;22814125
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Randomized Controlled Trial'];The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml.;2010;BACKGROUND;10.1097/QAD.0b013e3283348944;20010070
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Meta-Analysis', 'Review'];Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.;2011;BACKGROUND;10.1371/journal.pone.0022003;21811554
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen.;2011;BACKGROUND;10.1371/journal.pone.0023726;21886816
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Multicenter Study'];Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.;2012;BACKGROUND;10.1097/QAD.0b013e328353b066;22441252
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).;2005;BACKGROUND;10.1097/01.qai.0000180077.59159.f4;16249701
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Clinical Trial', 'Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.;2017;DERIVED;10.1016/S2352-3018(17)30069-3;28566227
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article'];The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial.;2007;BACKGROUND;10.1097/QAD.0b013e32814e6b1c;17545707
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Randomized Controlled Trial'];Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir.;2010;BACKGROUND;10.1097/QAD.0b013e32833db9a1;20802298
NCT01905059;Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa;False;2014;2017;['Journal Article', 'Randomized Controlled Trial'];Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).;2006;BACKGROUND;10.1097/01.aids.0000218542.08845.b2;16549962
NCT02916732;Zika Virus Infection's Pregnancy Consequences in French Department of America;False;2016;2019;['Journal Article'];Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas.;2018;RESULT;10.1056/NEJMoa1709481;29539287
NCT02916732;Zika Virus Infection's Pregnancy Consequences in French Department of America;False;2016;2019;['Journal Article'];Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016.;2021;RESULT;10.1371/journal.pntd.0009048;33657112
NCT02236832;Study of the Neural Basis of Analogical Reasoning;False;2015;2021;;;;;;
NCT01164436;Cohort of HIV Associated Lymphomas;False;2008;2017;;;;;;
NCT02157311;4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients;False;2014;2016;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.;2017;DERIVED;10.1093/jac/dkx434;29186458
NCT01534728;Identification of Hepatitis C Virus (HCV) Specific T Cells;False;2012;2014;;;;;;
NCT01331811;Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon);False;2011;2014;['Journal Article'];A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis.;2019;DERIVED;10.1542/peds.2018-2065;31455612
NCT01331811;Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon);False;2011;2014;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis.;2019;DERIVED;10.1093/cid/ciy897;30689814
NCT01331811;Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon);False;2011;2014;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.;2018;DERIVED;10.1016/S2352-3018(17)30206-0;29174612
NCT01331811;Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon);False;2011;2014;['Clinical Trial', 'Journal Article'];Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children.;2016;DERIVED;10.1093/cid/ciw036;26908804
NCT02214511;Biomarkers of Social Sensitivity in Major Depression;False;2014;2017;;;;;;
NCT04203628;Evaluation of Four Stool Processing Methods Combined With Xpert MTB/RIF Ultra for Diagnosis of Intrathoracic Paediatric TB (TB-Speed - Stool Processing);False;2020;2022;;;;;;
NCT02567071;Natural Microbiota Restoration After C-section Birth;False;2016;2019;;;;;;
NCT02052271;Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation;False;2014;2018;;;;;;
NCT02082171;Multidomain Intervention to Prevent Disability in Elders;False;2013;2016;;;;;;
NCT02150993;First-Line Treatment for HIV-2;False;2016;2019;['Journal Article', 'Randomized Controlled Trial'];Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.;2024;PUBMED;10.1016/S2352-3018(24)00085-7;38740027
NCT01698411;Study of the Influence of Sleep on Hemodynamic Parameters in Patients With Sleep Disorders;False;2012;2015;;;;;;
NCT01495897;Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study;False;2011;2014;;;;;;
NCT02931097;DBS of the MLR for Gait and Balance Disorders in PD Patients;False;2016;2020;;;;;;
NCT04288128;Integrated Functional Evaluation of the Cerebellum;False;2020;2022;['Journal Article', 'Multicenter Study'];Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.;2024;PUBMED;10.1002/mds.29757;38419144
NCT04288128;Integrated Functional Evaluation of the Cerebellum;False;2020;2022;['Journal Article', 'Comment'];ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study.;2024;PUBMED;10.1001/jamaophthalmol.2024.0001;38421662
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Journal Article', 'Multicenter Study'];Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.;2012;BACKGROUND;10.3851/IMP1916;22267473
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Journal Article'];Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration.;2014;BACKGROUND;10.1371/journal.pone.0085516;24465584
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Journal Article'];Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.;2013;BACKGROUND;10.1371/journal.pone.0074868;24058636
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.;2015;BACKGROUND;10.1194/jlr.M054510;25573889
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.;2015;BACKGROUND;10.1371/journal.pone.0144317;26636578
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Journal Article', 'Multicenter Study'];Does pregnancy affect the early response to cART?;2013;BACKGROUND;10.1097/QAD.0b013e32835ac8bc;23079802
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Journal Article'];Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset.;2016;SUSPICIOUS;10.1371/journal.ppat.1005774;27509048
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Journal Article', 'Multicenter Study'];Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.;2012;BACKGROUND;10.1097/QAD.0b013e32834dcf61;22008658
NCT03137797;Cohort of Patients Naive of Antiretroviral Treatment at Enrollment;False;2004;2016;['Journal Article'];Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.;2013;BACKGROUND;10.1371/journal.pone.0071473;23936509
NCT02453061;A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease;False;2015;2019;['Journal Article'];Huntington's Disease Clinical Trials Corner: June 2019.;2019;DERIVED;10.3233/JHD-199003;31381524
NCT02658253;Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults;False;2016;2019;['Journal Article', 'Randomized Controlled Trial'];PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.;2020;DERIVED;10.1016/S1473-3099(19)30739-X;32032566
NCT02658253;Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults;False;2016;2019;['Journal Article', 'Review'];Progress and Insights Toward an Effective Placental Malaria Vaccine.;2021;DERIVED;10.3389/fimmu.2021.634508;33717176
NCT02101398;Study of the Effect of Transcranial Stimulations in Aphasic Subject Within a Year of Their Stroke;False;2014;2016;;;;;;
NCT04409405;Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola);False;2020;2021;['Journal Article'];Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.;2024;PUBMED;10.1016/S1473-3099(23)00552-2;38043556
NCT00495651;Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO);False;2008;2015;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.;2017;DERIVED;10.5588/ijtld.17.0016;29297443
NCT00495651;Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO);False;2008;2015;['Journal Article', 'Randomized Controlled Trial'];Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.;2014;DERIVED;10.1371/journal.pone.0107245;25330161
NCT00495651;Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO);False;2008;2015;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.;2013;DERIVED;10.7448/IAS.16.1.18059;23639243
NCT00495651;Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO);False;2008;2015;['Journal Article', 'Randomized Controlled Trial'];Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'Ivoire.;2014;DERIVED;10.7448/IAS.17.1.18977;24985779
NCT00495651;Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO);False;2008;2015;['Journal Article'];Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.;2017;DERIVED;10.1093/cid/cix747;29020361
NCT00495651;Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO);False;2008;2015;['Journal Article', 'Randomized Controlled Trial'];Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults.;2022;DERIVED;10.1186/s12879-022-07082-2;35093007
NCT00495651;Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO);False;2008;2015;['Journal Article', 'Multicenter Study', 'Randomized Controlled Trial'];A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.;2015;DERIVED;10.1056/NEJMoa1507198;26193126
NCT02481453;Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis;False;2015;2018;['Journal Article', 'Review'];Evaluation and construction of diagnostic criteria for inclusion body myositis.;2014;BACKGROUND;10.1212/WNL.0000000000000642;24975859
NCT02481453;Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis;False;2015;2018;[];International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009.;2010;BACKGROUND;10.1016/j.nmd.2010.03.014;20413309
NCT02481453;Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis;False;2015;2018;['Journal Article'];Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial.;2021;PUBMED;10.1016/S2665-9913(20)30280-0;38273639
NCT02960698;Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study;False;2016;2018;;;;;;
NCT02172677;The Influence of Collective Schemas on Individual Memory;False;2014;2016;;;;;;
NCT01037777;RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7;False;2009;2017;['Journal Article'];Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.;2022;DERIVED;10.1212/WNL.0000000000200257;35264424
NCT01037777;RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7;False;2009;2017;['Journal Article'];Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.;2014;DERIVED;10.1136/jmedgenet-2013-102200;24780882
NCT01037777;RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7;False;2009;2017;['Clinical Trial', 'Journal Article', 'Multicenter Study'];Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.;2020;DERIVED;10.1016/S1474-4422(20)30235-0;32822634
NCT01037777;RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7;False;2009;2017;['Journal Article'];Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.;2013;DERIVED;10.1016/S1474-4422(13)70104-2;23707147
NCT02833961;Diffusion Spectroscopy in Stroke;False;2016;2019;['Journal Article'];Longitudinal Monitoring of Microstructural Alterations in Cerebral Ischemia with in Vivo Diffusion-weighted MR Spectroscopy.;2023;PUBMED;10.1148/radiol.220430;36318030
NCT02976298;Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control;False;2013;2015;;;;;;
NCT01842477;Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing;False;2013;2016;;;;;;
NCT02721745;Cause and Consequence of Neural Fatigue;False;2016;2020;;;;;;
